Dan Leonard
Stock Analyst at RBC Capital
(4.70)
# 758
Out of 4,509 analysts
503
Total ratings
59.7%
Success rate
13.3%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Downgraded: Hold | $62 → $73 | $71.23 | +2.48% | 21 | Jul 8, 2026 | |
| WAT Waters | Initiated Coverage: Buy | $370 → $435 | $376.39 | +15.57% | 24 | Jul 8, 2026 | |
| GH Guardant Health | Initiated Coverage: Buy | $175 → $185 | $160.11 | +15.55% | 18 | Jun 12, 2026 | |
| NTRA Natera | Initiated Coverage: Buy | $290 → $275 | $272.66 | +0.86% | 18 | Jun 11, 2026 | |
| A Agilent Technologies | Maintained: Buy | $165 → $153 | $135.20 | +13.17% | 35 | May 26, 2026 | |
| BIO Bio-Rad Laboratories | Initiated Coverage: Buy | $335 → $320 | $298.34 | +7.26% | 29 | May 14, 2026 | |
| DHR Danaher | Initiated Coverage: Buy | $270 → $200 | $199.05 | +0.48% | 26 | May 14, 2026 | |
| ILMN Illumina | Initiated Coverage: Buy | $135 → $170 | $191.20 | -11.09% | 40 | May 14, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $195 → $160 | $147.13 | +8.75% | 3 | May 14, 2026 | |
| TMO Thermo Fisher Scientific | Initiated Coverage: Hold | $615 → $490 | $534.07 | -8.25% | 27 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $11 → $9 | $11.29 | -20.28% | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $59.83 | -24.79% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $10 | $6.67 | +49.93% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 → $175 | $231.21 | -24.31% | 19 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $20 | $45.79 | -56.32% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 → $340 | $357.65 | -4.93% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52 | $41.56 | +25.12% | 17 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $240 | $207.83 | +15.48% | 17 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $13 | $16.07 | -22.22% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $220 | $167.97 | +30.98% | 7 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $28 | $19.82 | +41.27% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $300 → $305 | $536.17 | -43.12% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1,530 → $1,350 | $1,314.83 | n/a | 14 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $120 → $115 | $111.21 | n/a | 18 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $20 | $20.46 | n/a | 6 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $6.51 | n/a | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 960.00 | $915.50 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $7 | $21.43 | n/a | 2 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $320 | $275.68 | n/a | 15 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $160 → $145 | $206.00 | n/a | 15 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 → $95 | $123.97 | n/a | 7 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.0001 | n/a | 1 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $35 | $6.04 | n/a | 14 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $150.65 | n/a | 1 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.0006 | n/a | 5 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.62 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.93 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $88.96 | n/a | 1 | Jun 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.000001 | n/a | 4 | May 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.5 | $1.31 | n/a | 3 | May 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $15 | $0.8379 | n/a | 11 | Apr 12, 2016 |
Bio-Techne
Jul 8, 2026
Downgraded: Hold
Price Target: $62 → $73
Current: $71.23
Upside: +2.48%
Waters
Jul 8, 2026
Initiated Coverage: Buy
Price Target: $370 → $435
Current: $376.39
Upside: +15.57%
Guardant Health
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $175 → $185
Current: $160.11
Upside: +15.55%
Natera
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $290 → $275
Current: $272.66
Upside: +0.86%
Agilent Technologies
May 26, 2026
Maintained: Buy
Price Target: $165 → $153
Current: $135.20
Upside: +13.17%
Bio-Rad Laboratories
May 14, 2026
Initiated Coverage: Buy
Price Target: $335 → $320
Current: $298.34
Upside: +7.26%
Danaher
May 14, 2026
Initiated Coverage: Buy
Price Target: $270 → $200
Current: $199.05
Upside: +0.48%
Illumina
May 14, 2026
Initiated Coverage: Buy
Price Target: $135 → $170
Current: $191.20
Upside: -11.09%
Repligen
May 14, 2026
Initiated Coverage: Buy
Price Target: $195 → $160
Current: $147.13
Upside: +8.75%
Thermo Fisher Scientific
May 14, 2026
Initiated Coverage: Hold
Price Target: $615 → $490
Current: $534.07
Upside: -8.25%
May 14, 2026
Initiated Coverage: Hold
Price Target: $11 → $9
Current: $11.29
Upside: -20.28%
May 7, 2026
Rated: Hold
Price Target: $40 → $45
Current: $59.83
Upside: -24.79%
Mar 9, 2026
Rated: Buy
Price Target: $15 → $10
Current: $6.67
Upside: +49.93%
Feb 25, 2026
Maintained: Hold
Price Target: $170 → $175
Current: $231.21
Upside: -24.31%
Feb 19, 2026
Maintained: Hold
Price Target: $14 → $20
Current: $45.79
Upside: -56.32%
Feb 13, 2026
Maintained: Buy
Price Target: $355 → $340
Current: $357.65
Upside: -4.93%
Feb 9, 2026
Maintained: Hold
Price Target: $52
Current: $41.56
Upside: +25.12%
Feb 6, 2026
Maintained: Buy
Price Target: $280 → $240
Current: $207.83
Upside: +15.48%
Nov 5, 2025
Maintained: Buy
Price Target: $11 → $13
Current: $16.07
Upside: -22.22%
Oct 24, 2025
Maintained: Buy
Price Target: $260 → $220
Current: $167.97
Upside: +30.98%
Aug 6, 2025
Maintained: Hold
Price Target: $24 → $28
Current: $19.82
Upside: +41.27%
Jul 29, 2025
Downgraded: Sell
Price Target: $300 → $305
Current: $536.17
Upside: -43.12%
May 19, 2025
Upgraded: Buy
Price Target: $1,530 → $1,350
Current: $1,314.83
Upside: n/a
May 1, 2025
Upgraded: Buy
Price Target: $120 → $115
Current: $111.21
Upside: n/a
Mar 2, 2025
Maintained: Hold
Price Target: $25 → $20
Current: $20.46
Upside: n/a
Aug 8, 2024
Maintained: Hold
Price Target: $11
Current: $6.51
Upside: n/a
Apr 8, 2024
Maintained: Hold
Price Target: kr 960.00
Current: $915.50
Upside: n/a
Feb 14, 2023
Maintained: Sell
Price Target: $8 → $7
Current: $21.43
Upside: n/a
Feb 11, 2022
Maintained: Buy
Price Target: $340 → $320
Current: $275.68
Upside: n/a
Feb 4, 2022
Maintained: Hold
Price Target: $160 → $145
Current: $206.00
Upside: n/a
Oct 18, 2021
Maintained: Buy
Price Target: $86 → $95
Current: $123.97
Upside: n/a
Jul 14, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
Aug 14, 2019
Maintained: Hold
Price Target: $45 → $35
Current: $6.04
Upside: n/a
Dec 6, 2018
Initiated Coverage: Buy
Price Target: $280
Current: $150.65
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $7
Current: $0.0006
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $56.62
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $28.93
Upside: n/a
Jun 16, 2016
Rated: Hold
Price Target: n/a
Current: $88.96
Upside: n/a
May 23, 2016
Reiterated: Buy
Price Target: $4
Current: $0.000001
Upside: n/a
May 11, 2016
Reiterated: Hold
Price Target: $4.5 → $3.5
Current: $1.31
Upside: n/a
Apr 12, 2016
Maintained: Buy
Price Target: $20 → $15
Current: $0.8379
Upside: n/a